Knight Therapeutics | GUD - Operating Expenses



Knight Therapeutics reported CAD89.06M in Operating Expenses for its fiscal quarter ending in September of 2024.


Operating Expenses Change Date
Acasti Pharma USD 3.09M 49.05M Jun/2025
Alaunos Therapeutics USD 759K 391K Dec/2024
Aurora Cannabis CAD 118.24M 66.26M Jun/2025
Avita Medical AUD 28.36M 2.44M Dec/2024
Canopy Growth CAD 94.22M 4.36M Jun/2025
Cronos Group USD 37.84M 1.5M Jun/2025
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Moderna USD 1.04B 113M Jun/2025
Organigram Holdings CAD 72.9M 18.86M Jun/2025
Organon & Co USD 1.27B 144M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Tectonic Therapeutic USD 22.33M 8.34M Jun/2025
Tilray USD 253.17M 16.55M Nov/2024
Viatris USD 3.4B 2.88B Jun/2025
Xeris Pharmaceuticals USD 67.06M 8.64M Jun/2025